等温核酸増幅技術の市場規模、シェア、動向分析レポート：製品別、技術別（NASBA、HDA、LAMP、SDA、SPIA、NEAR）、用途別、最終用途別、地域別、セグメント予測、2023年～2030年

等温核酸増幅技術市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の等温核酸増幅技術市場規模は2030年までに106億9,860万米ドルに達する見込みです。

同市場は、2023年から2030年にかけてCAGR 12.3％で拡大すると予測されています。慢性疾患や感染症の迅速検査と早期発見に関する意識の大幅な高まりが、市場成長を促進する重要な要因になると予測されています。さらに、HIV、肝炎、性感染症の有病率の世界の上昇と、こうした疾患の診断にINAATを採用する動きが活発化していることも、市場成長の原動力になると予想されます。

INAATは、感染症の診断において、培養に基づく同定などの従来の方法に代わる、より高感度で正確かつ迅速な方法を提供します。同様に、INAAT技術は最小限のリソースしか必要とせず、サーマルサイクラーを必要とせずに使用できるため、このような技術の移植性が大幅に向上します。さらに、等温増幅法では、より安価な手順や機器を使用することができるため、発展途上国での導入が促進される可能性があります。特に、ジカウイルス、結核、インフルエンザなどの感染症が最近流行しているアジア太平洋やアフリカなどの地域は、市場拡大の大きなチャンスです。

INAAT製品に対する需要の高まりに対応するため、主要企業は最新のINAAT製品に対応した先進的な試薬を発売し、製品ポートフォリオの拡充を図っています。例えば、2022年3月、サーモフィッシャーサイエンティフィック社は、様々なウイルス病原体の検出を目的としたInvitrogen Super Script IV RT-LAMP Master Mixを発売しました。このような製品の上市は、幅広い用途におけるINAAT技術の有用性を高めることにより、市場の成長を後押ししています。

さらに、COVID-19は、SARS-CoV-2ウイルスの検出に使用される迅速かつ正確な検査代替法に対する需要を増加させることで、市場成長にプラスの影響を与えています。いくつかの主な企業は、新しいINAATベースのCOVID-19検査製品を開発し、米国FDAからそのような製品の緊急使用承認を取得しています。例えば、この分野で市販されている製品には、Grifols Diagnostic Solutions Inc.のProcleix SARS-CoV-2アッセイやLucira Health, Inc.のLucira CHECK-ITCOVID-19検査キットなどがあります。COVID-19によるこのような戦略的イニシアチブは、近い将来、市場の成長に大きな刺激を与えると思われます。

等温核酸増幅技術市場レポートハイライト

• 製品別では、熱安定性ポリメラーゼの普及、INAAT製品のような費用対効果の高い診断代替品への需要の高まりにより、2022年には試薬セグメントが最大の市場シェアを占めました。
• ループ媒介等温増幅（LAMP）技術は、複数の検出モードを使用でき、幅広いRNAおよびDNAターゲットを検出できることから、2022年に16.10%の最大シェアを占めました。
• 用途別では、感染症診断が2022年に35.25%の最大シェアを占めました。これは、世界的に感染症の流行が増加していること、PCRベースの技術よりもINAAT技術が有望な選択肢を提供していることに起因しています。
• 北米は42.68%のシェアを占め、2022年の世界市場を独占しました。これは、ヘルスケア分野の急成長と、Thermo Fisher Scientific, Inc.
• 市場セグメンテーションは2022年に40.13%の最大市場シェアを占めたが、これは迅速診断のためのINAAT技術の採用が増加していることと、世界の医療支出の増加別ものです。

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
  • セグメントの定義
• 地域の範囲
• 推定・予測のタイムライン
• 目的
• 調査手法
• 情報調達
  • 購入したデータベース
  • Gvrの内部データベース
  • 二次情報
  • 1次調査
• 情報またはデータ分析
  • データ分析モデル
• 市場の形成と検証
• モデル詳細
  • 商品フロー分析
• 二次情報のリスト
• 略語のリスト

第2章 エグゼクティブサマリー

• 市場スナップショット
• セグメントのスナップショット
• 競合情勢のスナップショット

第3章 市場変数、動向、および範囲

• 市場セグメンテーションと範囲
• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助的な市場見通し
• 市場動向と展望
• 市場力学
  • 世界中で慢性疾患の発生率が増加し、高齢化が進んでいる
  • 分子診断市場の盛り上がり
  • 低コストで効果的な診断手順に対する需要の高まり
  • 新興経済諸国における可処分所得の増加
  • PcrよりもInaatの採用の増加が市場を押し上げている
  • 核酸ベースの診断の小型化の進展
• 市場抑制要因分析
  • 厳格な規制の枠組み
  • 新しい診断技術に対する認識の欠如
• 事業環境分析
  • SWOT分析：要因別（政治・法律、経済・技術）
  • ポーターのファイブフォース分析
• COVID-19の影響分析

第4章 製品ビジネス分析

• 等温核酸増幅技術市場：製品変動分析
• 機器
  • 機器市場、2018～2030年（100万米ドル）
• キットと試薬
  • キットおよび試薬市場、2018-2030（100万米ドル）

第5章 テクノロジービジネス分析

• 等温核酸増幅技術市場：技術変動分析
• NASBA
  • NASBA市場、2018年～2030年（100万米ドル）
• HDA
  • HDA市場、2018年～2030年（100万米ドル）
• LAMP
  • LAMP市場、2018～2030（100万米ドル）
• SDA
  • SDA市場、2018年～2030年（100万米ドル）
• SPIA
  • SPIA市場、2018年～2030年（100万米ドル）
• NEAR
  • NEAR市場、2018年～2030年（100万米ドル）
• TMA
  • TMA市場、2018～2030年（100万米ドル）
• RCA
  • RCA市場、2018年～2030年（100万米ドル）
• RPA
  • RPA市場、2018年～2030年（100万米ドル）
• SMAP2
  • SMAP2市場、2018年～2030年（100万米ドル）
• その他
  • その他市場、2018-2030（100万米ドル）

第6章 用途ビジネス分析

• 等温核酸増幅市場：用途の変動分析
• 血液検査
  • 血液スクリーニング市場、2018-2030（100万米ドル）
• 感染症の診断
  • 感染症診断市場、2018年～2030年（100万米ドル）
• がん
  • がん市場、2018～2030年（100万米ドル）
• その他
  • その他市場、2018-2030（100万米ドル）

第7章 最終用途ビジネス分析

• 等温核酸増幅市場：最終用途の変動分析
• 病院
  • 病院市場、2018～2030年（100万米ドル）
• 中央および基準研究所
  • 中央および基準研究所市場、2018-2030（100万米ドル）
• その他
  • その他市場、2018-2030（100万米ドル）

第8章 地域ビジネス分析

• 等温核酸増幅技術市場：地域変動分析、2022年および2030年
• 北米
  • 北米の等温核酸増幅技術市場推計・予測、2018年～2030年（100万米ドル）
  • 米国
  • カナダ
• 欧州
  • 欧州の等温核酸増幅技術市場推計・予測、2018年から2030年（100万米ドル）
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • アジア太平洋の等温核酸増幅技術市場推計・予測、2018年～2030年（100万米ドル）
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ラテンアメリカの等温核酸増幅技術市場推計・予測、2018年～2030年（100万米ドル）
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東とアフリカ
  • 中東およびアフリカの等温核酸増幅技術市場推計・予測、2018年から2030年（100万米ドル）
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 会社の分類
• 戦略マッピング
  • 新製品の発売
  • パートナーシップ
  • 取得
  • コラボレーション
  • 資金調達
• 主要企業の市場シェア分析、2022年
• 企業プロファイル
  • Alere, Inc.
  • Biomerieux Sa
  • Eiken Chemical Co. Ltd
  • Hologic Inc.（Gen-Probe）
  • Lucigen
  • Meridian Bioscience, Inc.
  • Ustar Biotechnologies Ltd.
  • Qiagen
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.
  • Bd（Becton, Dickinson &Company）
  • Optigene Limited

List of Tables

• Table 1 Global Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 2 Global Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 3 Global Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 4 Global Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 5 North America Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 6 North America Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 7 North America Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 8 North America Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 9 Europe Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 10 Europe Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 11 Europe Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 12 Europe Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 13 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 14 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 15 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 16 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 17 Latin America Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 18 Latin America Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 19 Latin America Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 20 Latin America Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 21 Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 22 Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 23 Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 24 Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 25 U.S. Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 26 U.S. Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 27 U.S. Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 28 U.S. Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 29 Canada Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 30 Canada Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 31 Canada Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 32 Canada Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 33 Germany Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 34 Germany Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 35 Germany Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 36 Germany Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 37 UK Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 38 UK Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 39 UK Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 40 UK Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 41 France Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 42 France Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 43 France Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 44 France Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 45 Spain Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 46 Spain Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 47 Spain Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 48 Spain Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 49 Sweden Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 50 Sweden Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 51 Sweden Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 52 Sweden Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 53 Denmark Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 54 Denmark Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 55 Denmark Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 56 Denmark Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 57 Norway Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 58 Norway Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 59 Norway Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 60 Norway Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 61 China Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 62 China Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 63 China Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 64 China Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 65 Japan Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 66 Japan Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 67 Japan Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 68 Japan Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 69 India Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 70 India Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 71 India Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 72 India Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 73 South Korea Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 74 South Korea Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 75 South Korea Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 76 South Korea Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 77 Australia Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 78 Australia Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 79 Australia Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 80 Australia Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 81 Thailand Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 82 Thailand Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 83 Thailand Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 84 Thailand Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 85 Brazil Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 86 Brazil Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 87 Brazil Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 88 Brazil Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 89 Mexico Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 90 Mexico Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 91 Mexico Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 92 Mexico Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 93 Argentina Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 94 Argentina Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 95 Argentina Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 96 Argentina Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 97 South Africa Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 98 South Africa Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 99 South Africa Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 100 South Africa Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 101 Saudi Arabia Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 102 Saudi Arabia Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 103 Saudi Arabia Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 104 Saudi Arabia Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 105 UAE Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 106 UAE Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 107 UAE Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 108 UAE Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)
• Table 109 Kuwait Isothermal Nucleic Acid Amplification Technology Market, by Product, 2018 - 2030 (USD Million)
• Table 110 Kuwait Isothermal Nucleic Acid Amplification Technology Market, by Technology, 2018 - 2030 (USD Million)
• Table 111 Kuwait Isothermal Nucleic Acid Amplification Technology Market, by Application, 2018 - 2030 (USD Million)
• Table 112 Kuwait Isothermal Nucleic Acid Amplification Technology Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Isothermal Nucleic Acid Amplification Technology Market Segmentation
• Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 10 Penetration & Growth Prospect Mapping
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Global Isothermal Nucleic Acid Amplification Technology Market, for Instruments, 2018 - 2030 (USD Million)
• Fig. 14 Global Isothermal Nucleic Acid Amplification Technology Market, for Reagents, 2018 - 2030 (USD Million)
• Fig. 15 Global Isothermal Nucleic Acid Amplification Technology Market, for NASBA, 2018 - 2030 (USD Million)
• Fig. 16 Global Isothermal Nucleic Acid Amplification Technology Market, for HDA, 2018 - 2030 (USD Million)
• Fig. 17 Global Isothermal Nucleic Acid Amplification Technology Market, for LAMP, 2018 - 2030 (USD Million)
• Fig. 18 Global Isothermal Nucleic Acid Amplification Technology Market, for SDA, 2018 - 2030 (USD Million)
• Fig. 19 Global Isothermal Nucleic Acid Amplification Technology Market, for SPIA, 2018 - 2030 (USD Million)
• Fig. 20 Global Isothermal Nucleic Acid Amplification Technology Market, for NEAR, 2018 - 2030 (USD Million)
• Fig. 21 Global Isothermal Nucleic Acid Amplification Technology Market, for TMA, 2018 - 2030 (USD Million)
• Fig. 22 Global Isothermal Nucleic Acid Amplification Technology Market, for RCA, 2018 - 2030 (USD Million)
• Fig. 23 Global Isothermal Nucleic Acid Amplification Technology Market, for RPA, 2018 - 2030 (USD Million)
• Fig. 24 Global Isothermal Nucleic Acid Amplification Technology Market, for SMAP2, 2018 - 2030 (USD Million)
• Fig. 25 Global Isothermal Nucleic Acid Amplification Technology Market, for Others, 2018 - 2030 (USD Million)
• Fig. 26 Global Isothermal Nucleic Acid Amplification Technology Market, for Blood screening, 2018 - 2030 (USD Million)
• Fig. 27 Global Isothermal Nucleic Acid Amplification Technology Market, for Infectious disease diagnostics, 2018 - 2030 (USD Million)
• Fig. 28 Global Isothermal Nucleic Acid Amplification Technology Market, for Cancer, 2018 - 2030 (USD Million)
• Fig. 29 Global Isothermal Nucleic Acid Amplification Technology Market, for Others, 2018 - 2030 (USD Million)
• Fig. 30 Global Isothermal Nucleic Acid Amplification Technology Market, for Hospitals, 2018 - 2030 (USD Million)
• Fig. 31 Global Isothermal Nucleic Acid Amplification Technology Market, for Central and reference labs, 2018 - 2030 (USD Million)
• Fig. 32 Global Isothermal Nucleic Acid Amplification Technology Market, for Others, 2018 - 2030 (USD Million)
• Fig. 33 Regional Marketplace: Key Takeaways
• Fig. 34 Regional Outlook, 2021 & 2030
• Fig. 35 North America Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 36 U.S. Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 37 Canada Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 38 Europe Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 39 Germany Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 40 UK Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 41 France Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 42 Spain Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 43 Italy Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 44 Sweden Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 45 Denmark Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 46 Norway Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 47 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 48 Japan Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 49 China Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 50 India Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 51 Australia Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 52 South Korea Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 53 Thailand Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 54 Latin America Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 55 Brazil Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 56 Mexico Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 57 Argentina Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 58 Middle East and Africa Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 59 South Africa Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 60 Saudi Arabia Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 61 UAE Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)
• Fig. 62 Kuwait Isothermal Nucleic Acid Amplification Technology Market, 2018 - 2030 (USD Million)

Isothermal Nucleic Acid Amplification Technology Market Growth & Trends

The global isothermal nucleic acid amplification technology market size is expected to reach USD 10,698.6 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.3% from 2023 to 2030 A significant rise in awareness regarding the rapid testing and early detection of chronic and infectious diseases is expected to be a significant factor driving the market growth. Furthermore, the global growth in the prevalence of HIV, hepatitis, and sexually transmitted diseases, as well as the rise in adoption of INAAT for the diagnosis of such diseases, is anticipated to drive market growth.

INAAT offers a more sensitive, accurate, and rapid alternative to traditional methods, such as culture-based identification, for the diagnosis of infectious diseases. Similarly, INAAT techniques require minimal resources and are used without the need for thermal cyclers, which significantly improves the portability of such techniques. Moreover, isothermal amplification involves the use of less expensive procedures and equipment, which can fuel its adoption in developing countries. In particular, regions such as the Asia Pacific and Africa, that have recently witnessed epidemics of infectious diseases, such as Zika virus, tuberculosis, and influenza, present significant opportunities for market expansion.

To address the growing demand for INAAT offerings, key players are expanding their product portfolio by the launch of advanced reagents for the latest INAAT products. For instance, in March 2022, Thermo Fisher Scientific, Inc. launched its Invitrogen Super Script IV RT-LAMP Master Mix, intended for the detection of various viral pathogens. Such product launches are favoring market growth by increasing the utility of INAAT techniques for a broad range of applications.

Furthermore, COVID-19 has positively affected the market growth by increasing demand for the rapid and accurate testing alternatives used for the detection of the SARS-CoV-2 virus. Several key players have developed new INAAT-based COVID-19 testing products and have secured emergency use approvals for such products from the U.S. FDA. For instance, commercially available products in this domain include Grifols Diagnostic Solutions Inc.'s Procleix SARS-CoV-2 assay and Lucira Health, Inc.'s Lucira CHECK-IT COVID-19 test kit. Such strategic initiatives fueled by COVID-19 are likely to provide a significant stimulus to market growth in the near future.

Isothermal Nucleic Acid Amplification Technology Market Report Highlights

• By product, the reagents segment accounted for the largest market share in 2022 due to the widespread availability of thermo stable polymerases, and increasing demand for cost-effective diagnostic alternatives such as INAAT products
• Loop-mediated isothermal amplification (LAMP) technology accounted for the largest share of 16.10% in 2022 as the technique allows for the use of multiple modes of detection and has the ability to detect a broad range of RNA and DNA targets
• By application, infectious disease diagnostics held the largest share of 35.25% in 2022. This can be attributed to the rising prevalence of infectious disease, globally, and promising alternatives offered by INAAT technologies over PCR-based techniques
• North America held a share of 42.68% and dominated the global market in 2022, due to the rapid growth in the healthcare sector and the presence of key players such as Thermo Fisher Scientific, Inc., Quidel Corporation, Meridian Bioscience, Inc., and others within the region
• Hospitals end-use segment held the largest market share of 40.13% in 2022 due to the increasing adoption of INAAT techniques for rapid diagnostics and increasing global healthcare expenditure

Table of Contents

Chapter 1. Methodology And Scope

• 1.1 Market Segmentation And Scope
  • 1.1.1 Segment Definitions
    • 1.1.1.1 Test Segment
    • 1.1.1.2 Service Provider Segment
    • 1.1.1.3 Application Segment
• 1.2 Regional Scope
• 1.3 Estimates And Forecast Timeline
• 1.4 Objectives
  • 1.4.1 Objective - 1
  • 1.4.2 Objective - 2
  • 1.4.3 Objective - 3
• 1.5 Research Methodology
• 1.6 Information Procurement
  • 1.6.1 Purchased Database
  • 1.6.2 Gvr's Internal Database
  • 1.6.3 Secondary Sources
  • 1.6.4 Primary Research
• 1.7 Information Or Data Analysis
  • 1.7.1 Data Analysis Models
• 1.8 Market Formulation & Validation
• 1.9 Model Details
  • 1.9.1 Commodity Flow Analysis
• 1.10 List Of Secondary Sources
• 1.11 List Of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Segmentation And Scope
• 3.2. Market Lineage Outlook
  • 3.2.1 Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Trends And Outlook
• 3.4. Market Dynamics
  • 3.4.1 Increasing Incidences Of Chronic Diseases And Rise In The Aging Population Across The Globe
  • 3.4.2 Upsurge In The Molecular Diagnostics Market
  • 3.4.3 Rise In Demand For Low Cost And Effective Diagnostics Procedures
  • 3.4.4 Increase In The Available Disposable Income In The Developing Economies
  • 3.4.5 Increase In The Adoption Of Inaat Over Pcr Is Boosting The Market
  • 3.4.6 Rise In The Miniaturization Of Nucleic Acid-Based Diagnostics
• 3.5. Market Restraint Analysis
  • 3.5.1 Stringent Regulatory Framework
  • 3.5.2 Lack Of Awareness Over New Diagnostics Technologies
• 3.6. Business Environment Analysis
  • 3.6.1. Swot Analysis; By Factor (Political & Legal, Economic And Technological)
  • 3.6.2. Porter's Five Forces Analysis
• 3.7. Covid-19 Impact Analysis

Chapter 4. Product Business Analysis

• 4.1. Isothermal Nucleic Acid Amplification Technology Market: Product Movement Analysis
• 4.2. Instruments
  • 4.2.1 Instruments Market, 2018 - 2030 (USD Million)
• 4.3. Kits & Reagents
  • 4.3.1 Kits & Reagents Market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

• 5.1. Isothermal Nucleic Acid Amplification Technology Market: Technology Movement Analysis
• 5.2. NASBA
  • 5.2.1 NASBA Market, 2018 - 2030 (USD Million)
• 5.3. HDA
  • 5.3.1 HDA Market, 2018 - 2030 (USD Million)
• 5.4. LA MP
  • 5.4.1 LA MP Market, 2018 - 2030 (USD Million)
• 5.5. SDA
  • 5.5.1 SDA Market, 2018 - 2030 (USD Million)
• 5.6. SPIA
  • 5.6.1 SPIA Market, 2018 - 2030 (USD Million)
• 5.7. NEAR
  • 5.7.1. NEAR Market, 2018 - 2030 (USD Million)
• 5.8. TMA
  • 5.8.1. TMA Market, 2018 - 2030 (USD Million)
• 5.9. RCA
  • 5.9.1 RCA Market, 2018 - 2030 (USD Million)
• 5.10. RPA
  • 5.10.1 RPA Market, 2018 - 2030 (USD Million)
• 5.11. SMAP2
  • 5.11.1 SMAP2 Market, 2018 - 2030 (USD Million)
• 5.12. Others
  • 5.12.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

• 6.1. Isothermal Nucleic Acid Amplification Market: Application Movement Analysis
• 6.2. Blood Screening
  • 6.2.1 Blood Screening Market, 2018 - 2030 (USD Million)
• 6.3. Infectious Disease Diagnosis
  • 6.3.1 Infectious Disease Diagnosis Market, 2018 - 2030 (USD Million)
• 6.4. Cancer
  • 6.4.1. Cancer Market, 2018 - 2030 (USD Million)
• 6.5. Others
  • 6.5.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7. End-Use Business Analysis

• 7.1. Isothermal Nucleic Acid Amplification Market: End-Use Movement Analysis
• 7.2. Hospital
  • 7.2.1 Hospital Market, 2018 - 2030 (USD Million)
• 7.3. Central And Reference Laboratories
  • 7.3.1 Central And Reference Laboratories Market, 2018 - 2030 (USD Million)
• 7.4. Others
  • 7.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

• 8.1. Isothermal Nucleic Acid Amplification Technology Market: Regional Movement Analysis, 2022 & 2030
• 8.2. North America
  • 8.2.1 North America Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.2.2 U.S.
    • 8.2.1.1. Key Country Dynamics
    • 8.2.1.2. Competitive Scenario
    • 8.2.1.3. Prevalence Insights
    • 8.2.1.4. Regulatory Framework
    • 8.2.1.5. U.S. Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.2.3 Canada
    • 8.2.3.1 Key Country Dynamics
    • 8.2.3.2 Competitive Scenario
    • 8.2.3.3 Prevalence Insights
    • 8.2.3.4 Regulatory Framework
    • 8.2.3.5 Canada Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.3. Europe
  • 8.3.1 Europe Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2 Uk
    • 8.3.2.1 Key Country Dynamics
    • 8.3.2.2 Competitive Scenario
    • 8.3.2.3 Prevalence Insights
    • 8.3.2.4 Regulatory Framework
    • 8.3.2.5 Uk Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.3 Germany
    • 8.3.3.1 Key Country Dynamics
    • 8.3.3.2 Competitive Scenario
    • 8.3.3.3 Prevalence Insights
    • 8.3.3.4 Regulatory Framework
    • 8.3.3.5 Germany Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.4 France
    • 8.3.4.1 Key Country Dynamics
    • 8.3.4.2 Competitive Scenario
    • 8.3.4.3 Prevalence Insights
    • 8.3.4.4 Regulatory Framework
    • 8.3.4.5 France Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.5 Italy
    • 8.3.5.1 Key Country Dynamics
    • 8.3.5.2 Competitive Scenario
    • 8.3.5.3 Prevalence Insights
    • 8.3.5.4 Regulatory Framework
    • 8.3.5.5 Italy Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.6 Spain
    • 8.3.6.1 Key Country Dynamics
    • 8.3.6.2 Competitive Scenario
    • 8.3.6.3 Prevalence Insights
    • 8.3.6.4 Regulatory Framework
    • 8.3.6.5 Spain Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.7 Denmark
    • 8.3.7.1 Key Country Dynamics
    • 8.3.7.2 Competitive Scenario
    • 8.3.7.3 Prevalence Insights
    • 8.3.7.4 Regulatory Framework
    • 8.3.7.5 Denmark Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.8 Sweden
    • 8.3.8.1 Key Country Dynamics
    • 8.3.8.2 Competitive Scenario
    • 8.3.8.3 Prevalence Insights
    • 8.3.8.4 Regulatory Framework
    • 8.3.8.5 Sweden Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.9 Norway
    • 8.3.9.1 Key Country Dynamics
    • 8.3.9.2 Competitive Scenario
    • 8.3.9.3 Prevalence Insights
    • 8.3.9.4 Regulatory Framework
    • 8.3.9.5 Norway Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.4. Asia Pacific
  • 8.4.1 Asia Pacific Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2 Japan
    • 8.4.2.1 Key Country Dynamics
    • 8.4.2.2 Competitive Scenario
    • 8.4.2.3 Prevalence Insights
    • 8.4.2.4 Regulatory Framework
    • 8.4.2.5 Japan Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3 China
    • 8.4.3.1 Key Country Dynamics
    • 8.4.3.2 Competitive Scenario
    • 8.4.3.3 Prevalence Insights
    • 8.4.3.4 Regulatory Framework
    • 8.4.3.5 China Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4 India
    • 8.4.4.1 Key Country Dynamics
    • 8.4.4.2 Competitive Scenario
    • 8.4.4.3 Prevalence Insights
    • 8.4.4.4 Regulatory Framework
    • 8.4.4.5 India Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.5 Australia
    • 8.4.5.1 Key Country Dynamics
    • 8.4.5.2 Competitive Scenario
    • 8.4.5.3 Prevalence Insights
    • 8.4.5.4 Regulatory Framework
    • 8.4.5.5 Australia Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.6 Thailand
    • 8.4.6.1 Key Country Dynamics
    • 8.4.6.2 Competitive Scenario
    • 8.4.6.3 Prevalence Insights
    • 8.4.6.4 Regulatory Framework
    • 8.4.6.5 Thailand Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.7 South Korea
    • 8.4.7.1 Key Country Dynamics
    • 8.4.7.2 Competitive Scenario
    • 8.4.7.3 Prevalence Insights
    • 8.4.7.4 Regulatory Framework
    • 8.4.7.5 South Korea Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.5. Latin America
  • 8.5.1 Latin America Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2 Brazil
    • 8.5.2.1 Key Country Dynamics
    • 8.5.2.2 Competitive Scenario
    • 8.5.2.3 Prevalence Insights
    • 8.5.2.4 Regulatory Framework
    • 8.5.2.5 Brazil Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3 Mexico
    • 8.5.3.1 Key Country Dynamics
    • 8.5.3.2 Competitive Scenario
    • 8.5.3.3 Prevalence Insights
    • 8.5.3.4 Regulatory Framework
    • 8.5.3.5 Mexico Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4 Argentina
    • 8.5.4.1 Key Country Dynamics
    • 8.5.4.2 Competitive Scenario
    • 8.5.4.3 Prevalence Insights
    • 8.5.4.4 Regulatory Framework
    • 8.5.4.5 Argentina Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.6. Middle East & Africa
  • 8.6.1 Middle East & Africa Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2 South Africa
    • 8.6.2.1 Key Country Dynamics
    • 8.6.2.2 Competitive Scenario
    • 8.6.2.3 Prevalence Insights
    • 8.6.2.4 Regulatory Framework
    • 8.6.2.5 South Africa Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3 Saudi Arabia
    • 8.6.3.1 Key Country Dynamics
    • 8.6.3.2 Competitive Scenario
    • 8.6.3.3 Prevalence Insights
    • 8.6.3.4 Regulatory Framework
    • 8.6.3.5 Saudi Arabia Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4 UAE
    • 8.6.4.1 Key Country Dynamics
    • 8.6.4.2 Competitive Scenario
    • 8.6.4.3 Prevalence Insights
    • 8.6.4.4 Regulatory Framework
    • 8.6.4.5 UAE Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5 Kuwait
    • 8.6.5.1 Key Country Dynamics
    • 8.6.5.2 Competitive Scenario
    • 8.6.5.3 Prevalence Insights
    • 8.6.5.4 Regulatory Framework
    • 8.6.5.5 Kuwait Isothermal Nucleic Acid Amplification Technology Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Strategy Mapping
  • 9.2.1 New Product Launch
  • 9.2.2 Partnerships
  • 9.2.3 Acquisition
  • 9.2.4. Collaboration
  • 9.2.5 Funding
• 9.3. Key Company Market Share Analysis, 2022
• 9.4. Company Profiles
  • 9.4.1 Alere, Inc.
    • 9.4.1.1 Company Overview
    • 9.4.1.2 Financial Performance
    • 9.4.1.3 Product Benchmarking
    • 9.4.1.4 Strategic Initiatives
  • 9.4.2 Biomerieux Sa
    • 9.4.2.1 Company Overview
    • 9.4.2.2 Financial Performance
    • 9.4.2.3 Product Benchmarking
    • 9.4.2.4 Strategic Initiatives
  • 9.4.3 Eiken Chemical Co. Ltd
    • 9.4.3.1 Company Overview
    • 9.4.3.2 Financial Performance
    • 9.4.3.3 Product Benchmarking
    • 9.4.3.4 Strategic Initiatives
  • 9.4.4 Hologic Inc.(Gen-Probe)
    • 9.4.4.1 Company Overview
    • 9.4.4.2 Financial Performance
    • 9.4.4.3 Product Benchmarking
    • 9.4.4.4 Strategic Initiatives
  • 9.4.5 Lucigen
    • 9.4.5.1 Company Overview
    • 9.4.5.2 Financial Performance
    • 9.4.5.3 Product Benchmarking
    • 9.4.5.4 Strategic Initiatives
  • 9.4.6 Meridian Bioscience, Inc.
    • 9.4.6.1 Company Overview
    • 9.4.6.2 Financial Performance
    • 9.4.6.3 Product Benchmarking
    • 9.4.6.4 Strategic Initiatives
  • 9.4.7 Ustar Biotechnologies Ltd.
    • 9.4.7.1 Company Overview
    • 9.4.7.2 Financial Performance
    • 9.4.7.3 Product Benchmarking
    • 9.4.7.4 Strategic Initiatives
  • 9.4.8 Qiagen
    • 9.4.8.1 Company Overview
    • 9.4.8.2 Financial Performance
    • 9.4.8.3 Product Benchmarking
    • 9.4.8.4 Strategic Initiatives
  • 9.4.9 Quidel Corporation
    • 9.4.9.1 Company Overview
    • 9.4.9.2 Financial Performance
    • 9.4.9.3 Product Benchmarking
    • 9.4.9.4 Strategic Initiatives
  • 9.4.10 Thermo Fisher Scientific, Inc.
    • 9.4.10.1 Company Overview
    • 9.4.10.2 Financial Performance
    • 9.4.10.3 Product Benchmarking
    • 9.4.10.4 Strategic Initiatives
  • 9.4.11 Bd (Becton, Dickinson & Company)
    • 9.4.11.1 Company Overview
    • 9.4.11.2 Financial Performance
    • 9.4.11.3 Product Benchmarking
    • 9.4.11.4 Strategic Initiatives
  • 9.4.12 Optigene Limited
    • 9.4.12.1 Company Overview
    • 9.4.12.2 Financial Performance
    • 9.4.12.3 Product Benchmarking
    • 9.4.12.4 Strategic Initiatives